{"type":"rich","version":"1.0","provider_name":"Transistor","provider_url":"https://transistor.fm","author_name":"PIWORLD Investor Podcasts","title":"Accrol Group Holdings Interim results presentation - January 2023","html":"","width":"100%","height":180,"duration":2442,"description":"Accrol, CEO Gareth Jenkins, CFO, Richard Newman & Group Financial Controller (and CFO designate), Chris Welsh, present the interim results for the six months ended 31 October 2022.\n\"There was strong progress across all businesses and products. The Group has performed well in H2 to date and is on track to achieve revenue and adjusted EBITDA growth for the year ending 30 April 2023 (\"FY23\") marginally ahead of expectations at £230m and £15.5m respectively.\"\nGareth Jenkins, CEO00:16 - Introduction00:34 - HY22/23 Performance summary\nRichard Newman, CFO02:33 - Market and revenue overview03:47 - HY22/23 Financial summary07:21 - Half year commercial highlights08:28 - Half year operational highlights\nGareth Jenkins, CEO09:12 - ESG summary11:22 - FY23 outlook12:47 - Strategic review\nChris Welsh, Group Financial Controller (and CFO designate)16:55 - Strategic review continued\nGareth Jenkins, CEO18:29 - Summary\n20:11 - Q&A\nAccrol Group Holdings plc is a leading tissue converter and supplier of toilet tissues, kitchen rolls, facial tissues, and wet wipes to many of the UK's leading discounters and grocery retailers across the UK. Following the recent acquisitions of LTC in Leicester and JD in Flint, North Wales, the Group now operates from six manufacturing sites, including four in Lancashire, which generate volumes totalling c.21.5% of the c£2.5bn UK retail tissue market.\nFor more information, please visit www.accrol.co.uk.","thumbnail_url":"https://img.transistorcdn.com/oB5fNE4aIAia_YyTCKvE1PzrZQaD1Fjo_P7m7T9Aw_Y/rs:fill:0:0:1/w:400/h:400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9kOTJi/ODBiMzBmOGFhZWJi/MWEzYThkMzAyNmZm/MTdjZi5wbmc.webp","thumbnail_width":300,"thumbnail_height":300}